HGEN News and Press, Humanigen Inc. From 11/11/20

-Underwritten Public Offering and Nasdaq Listing Completed in September 2020 -Positive Phase 3 Interim Analysis Reported with an Estimated 37 percent More Recoveries Observed in the Lenzilumab Arm Versus Current Standard of Care Humanigen, Inc. , (HGEN)...

Greenland Technologies Holding (GTEC) +88% on launching integrated electric drivetrain.Trxade Group (MEDS) +70%.Summit Wireless Technologies (WISA) +42% on Q4 guidance.Mogo (MOGO) +27% on Q3 results.Fulgent Genetics (FLGT) +16% on Q3 results.Affime...

Gainers: Sundial Growers (SNDL) +79%.Aptevo Therapeutics (APVO) +60%.AMC Entertainment (AMC) +60%.Ashford Hospitality Trust (AHT) +58%.Cinemark Holdings (CNK) +56%.National CineMedia (NCMI) +48%.Tuniu (TOUR) +41%.EPR Properties (EPR) +41%.Dave & Buster's Entertainment (PLAY) +40%.Bro...

Pfizer and BioNTech's announcement that their COVID-19 vaccine candidate showed 90% efficacy based on a preliminary analysis of results from a pivotal study has stoked selling in therapy developers. If the higher-than-expected efficacy holds, herd immunity in the general population could pote...

Humanigen (HGEN) perks 11% after announcing positive interim Phase 3 data of lenzilumab in patients hospitalized with COVID-19.Lenzilumab had a clinically meaningful impact on patient recovery, with an estimated 37% more recoveries observed in the lenzilumab arm (HR of 1.37) vs. cur...

FTS International (FTSI) +67% after successful confirmation of plan of reorganization.Mogo (MOGO) +58% after announcing MogoSpend supports Apple Pay, Google Pay and Samsung Pay.GoPro (GPRO) +21% on Q3 results.Glu Mobile (GLUU) +17% on Q3 results.Aurora ...

Under the umbrella of Operation Warp Speed, Humanigen (HGEN) and a joint program unit within the U.S. Department Defense will collaborate with the Department of Health and Human Services' BARDA to develop lenzilumab, a monoclonal antibody designed to prevent and treat a potentially life-threa...

Interim data suggest clinically meaningful impact on patient recovery from COVID-19 with an estimated 37 percent more recoveries observed in lenzilumab arm of Phase 3 trial versus current standard of care Data safety monitoring board recommendation demonstrates the Phase 3 t...

Humanigen, Inc. , (Nasdaq:HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ by neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) wit...

Beasley Broadcast Group (BBGI) +54% on Q3 results.Alaska Communications Systems Group (ALSK) +56% after announcing agreement to be acquired by Macquarie Capital and GCM Grosvenor for $3.0 per share.JAKKS Pacific (JAKK) +18% on Q3 results.trivago N.V. (TRVG) +15%....